A tweet to help you learn about “Zhongke Huirun”
2025-12-08
Given the current imbalance in medical resources, how can we enable advanced MRI technology to break through geographical and cost barriers and benefit more grassroots patients? Today, we’ll take a closer look at Zhongke Huirun—a robust enterprise deeply rooted in the field of medical technology—and see how it’s leveraging the dual engines of “research + capital” to stay true to its original mission: “popularizing MRI, reducing the incidence of serious illnesses, and serving Healthy China.”
Dual-headquarters setup, solidifying the foundation for R&D and production.
As a national high-tech enterprise and a provincial specialized, refined, distinctive, and innovative enterprise, Zhongke Huirun has possessed an inherent sense of strength from the very beginning. The company boasts a 129-acre production base and a 50,000-square-meter R&D center, and has innovatively established two headquarters in Shenzhen and Baoding, creating an optimal “R&D + Production” layout.
Shenzhen headquarters, rooted in Nanshan Zhiyuan—a hub of innovation—focuses on R&D and breakthroughs in cutting-edge international technologies, striving to seize the technological high ground.
The Baoding headquarters has established itself in the Shenzhen Park in Baoding City, fully committed to building a scaled production system and providing robust capacity support for technology commercialization.
The two headquarters are working in synergy to ensure a smooth and efficient transition from the laboratory to the production line, laying a solid foundation for the company’s development.
 |
 |
Deeply rooted in scientific research and featuring a complete innovation chain.
The core competitiveness of Zhongke Huirun stems from its deeply ingrained scientific research DNA. As early as 2016, the company undertook the National Development and Reform Commission’s “Demonstration Project for the Popularization and Application of Magnetic Resonance Imaging” and received special national funding totaling 225 million yuan. This not only represents recognition at the national level but also underscores the company’s strong technological capabilities.
To build a complete innovation chain, Zhongke Huirun has established a robust “medical-engineering interdisciplinary” collaboration network. Its core partner institutions include research institutes such as the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and North China Electric Power University, as well as renowned medical institutions including the Hospital of Southern University of Science and Technology and the Naval Medical University. This collaborative model—combining research institutions with medical facilities—ensures that technological R&D remains closely aligned with clinical needs, thereby guaranteeing that innovative breakthroughs genuinely address pressing healthcare challenges.
Driven by both technological and capital forces, our barriers are solid and well-established.
On the growth trajectory of tech companies, the dual-drive model of “scientific research plus strong capital” often creates an overwhelming competitive advantage—and Zhongke Huirun is a prime example of this model in practice.
Technological Barriers: We have accumulated a total of 112 core intellectual property rights, including 18 invention patents, 82 utility model patents, and 12 design patents. Additionally, we hold 7 registered trademarks, 3 software patents, and 5 medical device certifications, creating an insurmountable technological moat. Moreover, our research capabilities are led by a team of academicians, placing us at the “ceiling” level in terms of scientific and technological strength.
Capital Backing: The company has secured joint investment from renowned investor Gong Hongjia, Zhuhai Gree, and Zhongke Tian Shi Investment. The participation of top-tier capital has injected strong momentum into the integration of industry and research as well as industrial transformation.
Our core products are robust and truly embody our original commitment to inclusivity.
All technological and capital investments must ultimately be reflected in the product. Zhongke Huirun’s core product—the conventional MRI—powerfully embodies the concept of “technology for the benefit of all,” with its strengths precisely addressing the pain points in the healthcare industry:
More Controllable Costs: With a power-off design and helium-free MRI standards, coupled with low power consumption and extremely low maintenance requirements, this solution significantly reduces operating costs for medical institutions, making it affordable even for grassroots hospitals.
Sharper Images: Equipped with CAS’s Dual Sync technology, this device features advanced technical specifications that ensure image clarity, providing strong support for doctors’ precise diagnoses.
Better scene adaptation: Whether it’s primary healthcare institutions or specialized scenarios with unique requirements, the system can respond flexibly, truly achieving the goal of “popularizing MRI.”
This advantage is no mere rhetoric—take, for example, the case of a hospital in Zhuozhou, Hebei Province: Previously, the hospital had been using a superconducting 1.5T MRI scanner, which incurred annual electricity costs of approximately 500,000 yuan and maintenance fees as high as 300,000 yuan, totaling 800,000 yuan in combined expenses—a situation that had long been unsustainable. After switching to a permanent-magnet MRI scanner from Zhongke Huiren, the hospital now spends only about 50,000 yuan annually on electricity and maintenance costs have dropped to as low as 10,000 to 20,000 yuan. As a result, the overall operating costs have been reduced by more than 20 times, completely resolving the core challenge faced by grassroots hospitals: “affordable to buy, but unaffordable to maintain.”
With our original aspiration firmly rooted, let’s jointly build a strong foundation for health.
From technological R&D to product implementation, from CAS laboratories to grassroots hospitals—Zhongke Huiren has consistently upheld the philosophy of “popularizing MRI and reducing the incidence of serious diseases.” Steadily advancing in the field of low-field MRI, it not only leverages technology to empower healthcare but also uses accessible and affordable imaging technologies to lay a solid health foundation for improving average life expectancy.
A medical technology company as strong and warm-hearted as this one is definitely worth our continued attention. What aspects of Zhongke Huirun’s core products are you curious about? Feel free to leave a comment and share your thoughts in the comments section—and don’t forget to like and share so that more people can learn about this cutting-edge enterprise that uses technology to safeguard health!
Here is the promotional video for Zhongke Huirun. Enjoy!
Recent News
Contact phone
Address: Building 4, Digital Industry Base, No. 555 Chuangzhi Road, Lianchi District, Baoding City, Hebei Province, China
Time: 8:00 a.m. - 12:00 p.m.; 2:00 p.m. - 5:30 p.m.